{"id":5139,"date":"2025-11-28T11:40:39","date_gmt":"2025-11-28T11:40:39","guid":{"rendered":"https:\/\/www.pharmakorell.com\/en\/?p=5139"},"modified":"2025-11-28T13:13:33","modified_gmt":"2025-11-28T13:13:33","slug":"pharmakorell-once-again-awarded-the-kununu-top-company-seal-2026","status":"publish","type":"post","link":"https:\/\/www.pharmakorell.com\/en\/pharmakorell-once-again-awarded-the-kununu-top-company-seal-2026\/","title":{"rendered":"PharmaKorell Once Again Awarded the kununu Top Company Seal 2026"},"content":{"rendered":"\n

\u2022 After being named a Top Company in 2024 and 2025<\/a>, PharmaKorell GmbH has also received the kununu Top Company Award for 2026 in recognition of its outstanding company culture.<\/p>\n\n\n\n

\u2022 The employer seal highlights organisations with high employee satisfaction and is awarded exclusively on the basis of independent reviews on kununu.<\/p>\n\n\n\n

\u2022\u00a0Around five per cent of all companies on kununu are recognised as a Top Company each year.<\/p>\n\n\n\n

\u2022 kununu CEO Nina Zimmermann: \u201cA strong signal to talents who are looking for their ideal employer.\u201d<\/p>\n\n\n\n

The employer review platform kununu has awarded PharmaKorell GmbH the Top Company Seal 2026. The award is based on the independent evaluations submitted by employees on the platform. This places PharmaKorell among the companies with the best working environment in Germany. \u201cWe congratulate PharmaKorell GmbH on once again receiving the Top Company Seal. Achieving this for the third consecutive year is something truly special,\u201d says Nina Zimmermann, CEO of kununu.<\/p>\n\n\n\n

\u201cOnly five per cent of companies qualify for this special seal. It sends a positive signal \u2013 both as a mark of quality for prospective applicants and as a reflection of a company\u2019s culture to its current employees. Seventy-one per cent of companies that received the seal reported an increase in applications. In addition, 81 per cent consider the award an important part of their employer branding strategy.\u201d<\/p>\n\n\n\n

\u201cWe are delighted to have been recognised as a kununu Top Company for the third year in a row,\u201d says Dr Ulrich Korell<\/a>, founder and Managing Director of PharmaKorell. <\/p>\n\n\n\n

\u201cConstructive collaboration and a positive working environment are extremely important at PharmaKorell. We place great value on ensuring that the rules for working together are agreed collectively within the team \u2013 either in the full group or through a smaller focus group chosen by the team \u2013 and that team decisions are supported and implemented by everyone. These team decisions cover a broad range of topics, such as our shared company values, the procedure for calculating the annual performance bonus, expectations around availability when working outside the office, which employee benefits we introduce, the selection of our new digital document system (eQMS), which charitable organisations we support as a company, the destination of our next team outing, the drinks and snacks provided free of charge, or which images we hang in the communal areas.\u201d<\/p>\n\n\n\n

A survey by kununu of companies that received the Top Company Seal during the previous award season found: 80 per cent of surveyed companies received positive feedback about the seal during the recruitment process. Furthermore, 81 per cent of award recipients would recommend that other employers pursue the Top Company qualification.<\/p>\n","protected":false},"excerpt":{"rendered":"

\u2022 After being named a Top Company in 2024 and 2025, PharmaKorell GmbH has also received the kununu Top Company Award for 2026 in recognition of its outstanding company culture. \u2022 The employer seal highlights organisations with high employee satisfaction and is awarded exclusively on the basis of independent reviews on kununu. \u2022\u00a0Around five per […]<\/p>\n","protected":false},"author":1,"featured_media":5140,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-5139","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","post-wrapper"],"_links":{"self":[{"href":"https:\/\/www.pharmakorell.com\/en\/wp-json\/wp\/v2\/posts\/5139","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmakorell.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharmakorell.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharmakorell.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharmakorell.com\/en\/wp-json\/wp\/v2\/comments?post=5139"}],"version-history":[{"count":3,"href":"https:\/\/www.pharmakorell.com\/en\/wp-json\/wp\/v2\/posts\/5139\/revisions"}],"predecessor-version":[{"id":5143,"href":"https:\/\/www.pharmakorell.com\/en\/wp-json\/wp\/v2\/posts\/5139\/revisions\/5143"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pharmakorell.com\/en\/wp-json\/wp\/v2\/media\/5140"}],"wp:attachment":[{"href":"https:\/\/www.pharmakorell.com\/en\/wp-json\/wp\/v2\/media?parent=5139"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharmakorell.com\/en\/wp-json\/wp\/v2\/categories?post=5139"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharmakorell.com\/en\/wp-json\/wp\/v2\/tags?post=5139"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}